The common antibiotic doxycycline can disrupt the formation of negative associations in the brain, according to new research from UCL and the University of Zurich.
The study, published in Molecular Psychiatry, was a pre-registered, placebo-controlled, double-blind randomised controlled trial in 76 healthy volunteers.
In the first session, participants were given either doxycycline or a placebo and learnt to associate a certain colour with an electric shock. A week later they were shown the colours again, accompanied by a loud sound but no shocks, and their fear responses were measured.*
The fear response was 60% lower in participants who had doxycycline in the first session compared to those who had the placebo, suggesting that the fear memory was significantly suppressed by the drug. Other cognitive measures including sensory memory and attention were not affected.
“When we talk about reducing fear memory, we are not talking about deleting the memory of what actually happened,” explains lead author Professor Dominik Bach (UCL Wellcome Centre for Neuroimaging, Max Planck UCL Centre for Computational Psychiatry and Ageing Research and University of Zurich Division of Clinical Psychiatry Research). “The participants may not forget that they received a shock when the screen was red, but they ‘forget’ to be instinctively scared when they next see a red screen. Learning to fear threats is an important ability for any organism, helping us to avoid dangers such as predators. Over-prediction of threat, however, can cause tremendous suffering and distress in anxiety disorders such as PTSD.”
Post-traumatic stress disorder (PTSD) is a term for a broad range of psychological symptoms that can develop after someone experiences or witnesses a traumatic event. PTSD is caused by an overactive fear memory, and the new research shows that doxycycline can reduce the fear memory response in healthy volunteers.
“We have demonstrated a proof-of-principle for an entirely new treatment strategy for PTSD,” explains Professor Bach. “The theory is based on the recent discovery that our brains need proteins outside nerve cells, called matrix enzymes, to form memories. Matrix enzymes are found throughout the body, and their over-activity is involved in certain immune diseases and cancers. To treat such diseases, we already have clinically approved drugs that block these enzymes, including the antibiotic doxycycline, so we wanted to see if they could help to prevent fear memories from forming in the brain. Our results support this theory, opening up an exciting avenue of research that might help us to find treatments for PTSD.
“Using drugs to prevent PTSD would be challenging, since in the real world we don’t know when a traumatic event is about to occur. However, there is growing evidence that people’s memories and associations can be changed after the event when they experience or imagine similar situations. This is called ‘reconsolidation’, and we now plan to test the effect of doxycycline on reconsolidation of fear memories. If this is successful, we would hope to apply the technique to more clinically realistic models of PTSD within a few years.”
The work was supported by the Swiss National Science Foundation, University of Zurich and Wellcome.
*In the first session, participants were given either doxycycline or a placebo and put in front of a computer. The screen would flash either blue or red, and one of the colours was associated with a 50% chance of receiving a painful electric shock. This happened 160 times, with the colours appearing in random order, so that participants learnt to associate the ‘bad’ colour with the shock.
A week later, under no medication, participants returned to repeat the experiment. This time there were no electric shocks, but a loud sound played after either colour was shown. Participants’ fear responses were measured by tracking their eye blinks, as this is an instinctive response to sudden threats. The fear memory response was calculated by subtracting the baseline startle response – the response to the sound on the ‘good’ colour – from the response to the sound when the ‘bad’ colour was showing
Learn more: Common antibiotic may help to prevent or treat PTSD
[osd_subscribe categories=’doxycycline’ placeholder=’Email Address’ button_text=’Subscribe Now for any new posts on the topic “DOXYCYCLINE”‘]
The Latest on: Doxycycline
[google_news title=”” keyword=”doxycycline” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Doxycycline
- Doxycycline and Sitafloxacin Combination Therapy for Treating Highly Resistant Mycoplasma genitaliumon June 6, 2023 at 4:59 pm
Duygu Durukan; Michelle Doyle; Gerald Murray; Kaveesha Bodiyabadu; Lenka Vodstrcil; Eric P.F. Chow; Jorgen S. Jensen; Christopher K. Fairley; Ivette Aguirre; Catriona ...
- Alabama faces shortage of drug that treats dangerous infection for newbornson June 1, 2023 at 3:36 pm
The medication used to treat syphilis is in short supply in Alabama, threatening efforts to reduce the number of babies exposed to the infection.
- Can You Drink Alcohol While Taking Doxycycline?on May 29, 2023 at 5:00 pm
An occasional drink or two while taking doxycycline is usually fine, but people who drink heavily may want to choose a different antibiotic. Heavy drinking could make doxycycline less effective.
- This Pill Is Being Touted as the Morning-After Pill For STIs - Here's What to Knowon May 18, 2023 at 9:22 am
S exually transmitted infections, or STIs, are incredibly common. In fact, one in five people have an STI, according to the Centers for Disease Control and Prevention (CDC). And in 2021 alone, ...
- Oral azithromycin equivalent to six weeks doxycycline for meibomian gland dysfunctionon March 31, 2023 at 1:04 pm
Would you like to receive trending story notifications on your smartphone? Three weeks of oral azithromycin seems to be equivalent to six weeks of doxycycline for treatment of severe meibomian ...
- Doxycycline - Indications, Dosage, Side Effects and Precautionson April 3, 2022 at 3:06 pm
Latest prescription information about Doxycycline. Learn how to pronounce the drug's name, its indications, dosage, how to take, when to take, when not to take, side effects, special precautions ...
- Common questions about doxycyclineon January 21, 2022 at 2:07 pm
Doxycycline is from a group of medicines called tetracycline antibiotics. These antibiotics work by killing bacteria by stopping them from making the proteins that they need to survive. For conditions ...
- Doxycycline and Sitafloxacin Combination Therapy for Treating Highly Resistant Mycoplasma genitaliumon August 27, 2020 at 8:57 am
*Doxy, doxycycline; Moxi, moxifloxacin; Pris, pristinamycin; TOC, test of cure; +, macrolide-resistant M. genitalium detected. †Doxycycline 100 mg 2 times/day ...
- Doxycycline Hyclate Periodontal Side Effects by Likelihood and Severityon August 14, 2013 at 8:14 pm
This survey is being conducted by the WebMD marketing sciences department. Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been ...
via Bing News